CURX Curanex Pharmaceuticals Inc - Common Stock

NASDAQ · Pharmaceuticals · View on SEC EDGAR ↗
$0.24
Price · Aug 19, 2026
Fundamentals as of Aug 14, 2026
52W Range
$0–$9
1% of range
Analyst Rating
—
Price Target
—
P/E (TTM)
-1.4
ROE
-73.3%
Net Profit Margin
—

CURX Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range

Price
$0.24
Market Cap
$7M
P/E (TTM)
-1.4
EPS (TTM)
$-0.17
Revenue (TTM)
—
Div Yield
—
ROE
-73.3%
Debt/Equity
—
52W Range
$0 – $9

CURX Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view

10-Year Performance Revenue, net income, margins and EPS trends

Revenue & Net Income —
EPS $-0.17
2-point trend, -466.7%
2024-12-31 → 2025-12-31
Free Cash Flow —
Margins —

Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?

Metric
5Y trend
CURX
Peer Median
P/E (TTM)
-1.4
44.2
P/B
0.6
2.0

Profitability Gross, operating and net margins; ROE, ROA, ROIC

Metric
5Y trend
CURX
Peer Median
ROA
-69.8%
-107.7%
ROE
-73.3%
-129.3%

Financial Health Debt, liquidity, solvency — balance sheet strength

Metric
5Y trend
CURX
Peer Median
Current Ratio
81.9
3.8
Quick Ratio
36.5
—

Growth Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR

Metric
5Y trend
CURX
Peer Median

Per Share Metrics EPS, book value per share, cash flow per share, dividend per share

Metric
5Y trend
CURX
Peer Median
EPS (Diluted)
2-point trend, -466.7%
$-0.17
—

Capital Efficiency Asset turnover, inventory turnover, receivables turnover

Metric
5Y trend
CURX
Peer Median

Peer comparison (GICS sub-industry) Key metrics vs sector peers

Ticker Market Cap P/E Rev YoY Net Margin ROE Gross Margin
CURX $9M -1.9 — — -73.3% —
PCSA — -0.3 — — — —
RVPH $2M — — — -485.2% —
SNES $11M -1.1 19.6% -287.4% -77.2% 62.5%
CVKD $16M -1.0 — — -376.2% —
SNOA $4M -1.1 36.7% -16.3% -92.3% 38.0%
ENVB $4M -0.1 -94.1% 8275459.4% -275.8% —
PULM $8M -1.6 7.0% — -109.7% —

Full Fundamentals All metrics by year — income statement, balance sheet, cash flow

Income Statement 10
Annual Income Statement data for CURX
Metric Trend 20252024
R&D Expense $3M ·
SG&A Expense 2-point trend, +331.6% $1M $290.4K
Operating Expenses 2-point trend, +1061.2% $4M $365.1K
Operating Income 2-point trend, -1061.2% $-4M $-365.1K
Net Income 2-point trend, -1068.8% $-4M $-361.5K
EPS (Basic) 2-point trend, -466.7% $-0.17 $-0.03
EPS (Diluted) 2-point trend, -466.7% $-0.17 $-0.03
Shares (Basic) 2-point trend, +92.3% 25,497,328 13,259,016
Shares (Diluted) 2-point trend, +92.3% 25,497,328 13,259,016
EBITDA $-4M ·
Balance Sheet 15
Annual Balance Sheet data for CURX
Metric Trend 20252024
Cash & Equivalents 2-point trend, +3258.2% $5M $148.9K
Prepaid Expense 2-point trend, +530381.3% $6M $1.2K
Other Current Assets · $367.9K
Current Assets 2-point trend, +2067.7% $11M $517.9K
Total Assets 2-point trend, +2135.8% $12M $517.9K
Accounts Payable 2-point trend, -51.5% $2.4K $5.0K
Accrued Liabilities 2-point trend, +24.4% $11.9K $9.6K
Current Liabilities 2-point trend, +840.2% $137.0K $14.6K
Capital Leases $224.0K ·
Total Liabilities 2-point trend, +2377.1% $361.0K $14.6K
Common Stock 2-point trend, +18.1% $2.8K $2.4K
Retained Earnings 2-point trend, -678.8% $-5M $-622.4K
Stockholders' Equity 2-point trend, +2128.8% $11M $503.4K
Liabilities + Equity 2-point trend, +2135.8% $12M $517.9K
Shares Outstanding 2-point trend, +18.1% 28,340,812 24,000,000
Cash Flow 3
Annual Cash Flow data for CURX
Metric Trend 20252024
Operating Cash Flow 2-point trend, -1787.1% $-10M $-555.6K
Stock Issued · $630.0K
Financing Cash Flow 2-point trend, +2329.6% $15M $630.1K
Profitability 2
Annual Profitability data for CURX
Metric Trend 20252024
ROA -69.8% ·
ROE -73.3% ·
Liquidity & Solvency 2
Annual Liquidity & Solvency data for CURX
Metric Trend 20252024
Current Ratio 81.9 ·
Quick Ratio 36.5 ·
Per Share 4
Annual Per Share data for CURX
Metric Trend 20252024
Book Value / Share $0.40 ·
Cash Flow / Share $-0.41 ·
Cash / Share $0.18 ·
EPS (TTM) $-0.17 ·
Valuation (TTM) 7
Annual Valuation (TTM) data for CURX
Metric Trend 20252024
Net Income TTM $-4M ·
Market Cap $9M ·
P/E -1.9 ·
P/B 0.8 ·
P / Tangible Book 0.8 ·
P / Cash Flow -0.9 ·
Earnings Yield -51.4% ·

Financial Statements Income statement, balance sheet, cash flow — annual, last 5 years

Income Statement
2025-12-312024-12-31
Net Income $-4M$-361.5K
Diluted EPS $-0.17$-0.03
Balance Sheet
2025-12-312024-12-31
Current Ratio 81.9—
Quick Ratio 36.5—

My Metrics Your personal watchlist — selected rows from Full Fundamentals

📊

Pick the metrics that matter to you — click the ➕ next to any row in Full Fundamentals above.

Your selection is saved and follows you across all tickers.

Institutional owners (13F) 11 filers · $73K total · As of June 30, 2026

Institutions that report holding this stock in their quarterly SEC Form 13F. Long positions only; a single filer may appear twice for separate option legs. Large offsetting put/call legs typically reflect market-making or hedged inventory, not directional conviction.

Institutional activity — Q2 2026 vs prior quarter
New positions Exited positions Increased Decreased Net shares change
6 (+4 vs prior Q) 3 (-1 vs prior Q) 2 (-1 vs prior Q) 3 (0 vs prior Q) -183

Compared to Q1 2026. SEC Form 13F filings are due within 45 days of quarter-end plus a short buffer for late filers — quarters still inside that window are skipped in favor of the most recent fully-reported pair.

Institution Value Shares % of tracked 13F Type
CITADEL ADVISORS LLC $25,262 95,258 34.46% Shares
RENAISSANCE TECHNOLOGIES LLC $13,790 52,000 18.81% Shares
GEODE CAPITAL MANAGEMENT, LLC $10,153 38,288 13.85% Shares
TWO SIGMA INVESTMENTS, LP $7,254 27,354 9.90% Shares
JANE STREET GROUP, LLC $6,931 26,135 9.46% Shares
SUSQUEHANNA INTERNATIONAL GROUP, LLP $3,887 14,657 5.30% Shares
Ground Swell Capital, LLC $3,352 12,638 4.57% Shares
CITIGROUP INC $2,375 8,957 3.24% Shares
Tower Research Capital LLC (TRC) $265 1,000 0.36% Shares
UBS Group AG $15 55 0.02% Shares
Virtu Financial LLC $14 51,236 0.02% Shares